Related Experiment Videos
CA 125 in benign gynecological conditions
1Department of Obstetrics and Gynecology, University of Göttingen, Germany.
The International Journal of Biological Markers
|May 6, 1999
Summary
The tumor marker CA 125, initially specific for ovarian cancer, is also elevated in many benign conditions. This indicates CA 125 reflects non-specific peritoneal issues, not just gynecological malignancies.
Area of Science:
- Oncology
- Gynecology
- Immunology
Background:
- The tumor marker CA 125 was initially considered specific for ovarian malignancies.
- However, elevated CA 125 levels have been observed in various non-malignant conditions.
Purpose of the Study:
- To evaluate the specificity of CA 125 as a tumor marker for ovarian cancer.
- To identify benign conditions associated with elevated CA 125 levels.
Main Methods:
- Literature review of studies reporting CA 125 levels.
- Analysis of CA 125 levels in patients with ovarian malignancies and benign conditions.
Main Results:
- CA 125 is elevated in numerous benign conditions, including pregnancy, pelvic inflammatory disease, tuberculosis, and liver cirrhosis.
- Elevated CA 125 is also noted in gynecological conditions such as benign ovarian cysts, tubo-ovarian abscess, endometriosis, hyperstimulation syndrome, ectopic pregnancy, and fibroids.
Conclusions:
- CA 125 is not a specific marker for ovarian malignancies.
- Elevated CA 125 levels are indicative of non-specific peritoneal conditions.